Oncimmune Holdings plc (ONC.L) (LON:ONC) insider Cheung To sold 10,000 shares of Oncimmune Holdings plc (ONC.L) stock in a transaction on Friday, January 8th. The shares were sold at an average price of GBX 185 ($2.42), for a total value of £18,500 ($24,170.37).
Cheung To also recently made the following trade(s):
- On Monday, January 11th, Cheung To sold 40,000 shares of Oncimmune Holdings plc (ONC.L) stock. The shares were sold at an average price of GBX 185 ($2.42), for a total value of £74,000 ($96,681.47).
Shares of ONC stock opened at GBX 189 ($2.47) on Thursday. The firm has a market cap of £120.32 million and a price-to-earnings ratio of -14.10. Oncimmune Holdings plc has a 12 month low of GBX 30 ($0.39) and a 12 month high of GBX 200 ($2.61). The company has a quick ratio of 1.74, a current ratio of 1.80 and a debt-to-equity ratio of 375.32. The stock has a 50-day moving average price of GBX 169.49 and a 200 day moving average price of GBX 154.75.
Oncimmune Holdings plc develops and commercializes products to diagnose cancer in the United Kingdom, North America, Europe, and internationally. It offers EarlyCDT-Lung, a blood test for early detection of lung cancer. The company also develops EarlyCDT-Liver, a blood test for the early detection of hepatocellular carcinoma in high-risk patients with liver lesions of all sizes; SeroTag, a platform that is used to discover and validate biomarkers and develop precision diagnostic tools from minimally-invasive liquid biopsies; and NavigAID for autoimmune diseases.
Receive News & Ratings for Oncimmune Holdings plc (ONC.L) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oncimmune Holdings plc (ONC.L) and related companies with MarketBeat.com's FREE daily email newsletter.